Home
>
National Drug Code (NDC)
>
tizanidine
tizanidine - 57664-503-83 - (tizanidine)
Drug Information of tizanidine
| Product NDC: | 57664-503 |
| Proprietary Name: | tizanidine |
| Non Proprietary Name: | tizanidine |
| Active Ingredient(s): | 4 mg/1 & nbsp; tizanidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of tizanidine
| Product NDC: | 57664-503 |
| Labeler Name: | CARACO PHARMACEUTICAL LABORATORIES, LTD. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076416 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20031211 |
Package Information of tizanidine
| Package NDC: | 57664-503-83 |
| Package Description: | 30 TABLET in 1 BOTTLE (57664-503-83) |
NDC Information of tizanidine
| NDC Code | 57664-503-83 |
| Proprietary Name | tizanidine |
| Package Description | 30 TABLET in 1 BOTTLE (57664-503-83) |
| Product NDC | 57664-503 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tizanidine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20031211 |
| Marketing Category Name | ANDA |
| Labeler Name | CARACO PHARMACEUTICAL LABORATORIES, LTD. |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
